PharmaShots | Incisive News in 3 Shots

Subscribe Now

AryoGen Pharmed

Insights+ Key Biosimilars Events of August 2022

Insights+ Key Biosimilars Events of August 2022

September 1, 2022

AryoGen Pharmed Reports P-III Trial Results of Denosumab Biosimilar Demonstrates Noninferiority to Prolia for Postmenopausal Osteoporosis

AryoGen Pharmed Reports P-III Trial Results of Denosumab Biosimilar Demonstrates Noninferiority to Prolia for Postmenopausal Osteo...

July 31, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us